ITRM
Price
$1.54
Change
-$0.00 (-0.00%)
Updated
Jan 17 closing price
Capitalization
42.37M
71 days until earnings call
VKTX
Price
$32.65
Change
+$0.09 (+0.28%)
Updated
Jan 17 closing price
Capitalization
3.64B
17 days until earnings call
Ad is loading...

ITRM vs VKTX

Header iconITRM vs VKTX Comparison
Open Charts ITRM vs VKTXBanner chart's image
Iterum Therapeutics
Price$1.54
Change-$0.00 (-0.00%)
Volume$537.43K
Capitalization42.37M
Viking Therapeutics
Price$32.65
Change+$0.09 (+0.28%)
Volume$4.39M
Capitalization3.64B
ITRM vs VKTX Comparison Chart
Loading...
ITRM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ITRM vs. VKTX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ITRM is a Hold and VKTX is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (ITRM: $1.54 vs. VKTX: $32.65)
Brand notoriety: ITRM and VKTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ITRM: 48% vs. VKTX: 117%
Market capitalization -- ITRM: $42.37M vs. VKTX: $3.64B
ITRM [@Biotechnology] is valued at $42.37M. VKTX’s [@Biotechnology] market capitalization is $3.64B. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ITRM’s FA Score shows that 1 FA rating(s) are green whileVKTX’s FA Score has 0 green FA rating(s).

  • ITRM’s FA Score: 1 green, 4 red.
  • VKTX’s FA Score: 0 green, 5 red.
According to our system of comparison, ITRM is a better buy in the long-term than VKTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ITRM’s TA Score shows that 3 TA indicator(s) are bullish while VKTX’s TA Score has 4 bullish TA indicator(s).

  • ITRM’s TA Score: 3 bullish, 1 bearish.
  • VKTX’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, ITRM is a better buy in the short-term than VKTX.

Price Growth

ITRM (@Biotechnology) experienced а -6.67% price change this week, while VKTX (@Biotechnology) price change was -16.94% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.66%, and the average quarterly price growth was -1.92%.

Reported Earning Dates

ITRM is expected to report earnings on May 14, 2025.

VKTX is expected to report earnings on Apr 23, 2025.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VKTX($3.64B) has a higher market cap than ITRM($42.4M). ITRM YTD gains are higher at: -12.994 vs. VKTX (-18.862). ITRM has higher annual earnings (EBITDA): -27.68M vs. VKTX (-133.66M). VKTX has more cash in the bank: 930M vs. ITRM (14.5M). VKTX has less debt than ITRM: VKTX (1.24M) vs ITRM (22.4M). ITRM (0) and VKTX (0) have equivalent revenues.
ITRMVKTXITRM / VKTX
Capitalization42.4M3.64B1%
EBITDA-27.68M-133.66M21%
Gain YTD-12.994-18.86269%
P/E RatioN/AN/A-
Revenue00-
Total Cash14.5M930M2%
Total Debt22.4M1.24M1,814%
FUNDAMENTALS RATINGS
ITRM vs VKTX: Fundamental Ratings
ITRM
VKTX
OUTLOOK RATING
1..100
6572
VALUATION
overvalued / fair valued / undervalued
1..100
88
Overvalued
48
Fair valued
PROFIT vs RISK RATING
1..100
10060
SMR RATING
1..100
10092
PRICE GROWTH RATING
1..100
4664
P/E GROWTH RATING
1..100
2100
SEASONALITY SCORE
1..100
5075

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VKTX's Valuation (48) in the Biotechnology industry is somewhat better than the same rating for ITRM (88). This means that VKTX’s stock grew somewhat faster than ITRM’s over the last 12 months.

VKTX's Profit vs Risk Rating (60) in the Biotechnology industry is somewhat better than the same rating for ITRM (100). This means that VKTX’s stock grew somewhat faster than ITRM’s over the last 12 months.

VKTX's SMR Rating (92) in the Biotechnology industry is in the same range as ITRM (100). This means that VKTX’s stock grew similarly to ITRM’s over the last 12 months.

ITRM's Price Growth Rating (46) in the Biotechnology industry is in the same range as VKTX (64). This means that ITRM’s stock grew similarly to VKTX’s over the last 12 months.

ITRM's P/E Growth Rating (2) in the Biotechnology industry is significantly better than the same rating for VKTX (100). This means that ITRM’s stock grew significantly faster than VKTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ITRMVKTX
RSI
ODDS (%)
N/A
Bullish Trend 12 days ago
76%
Stochastic
ODDS (%)
Bullish Trend 12 days ago
81%
Bullish Trend 12 days ago
83%
Momentum
ODDS (%)
Bullish Trend 12 days ago
82%
Bearish Trend 12 days ago
90%
MACD
ODDS (%)
N/A
Bullish Trend 12 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 12 days ago
85%
Bullish Trend 12 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 12 days ago
90%
Bearish Trend 12 days ago
85%
Advances
ODDS (%)
Bullish Trend 14 days ago
86%
Bullish Trend 17 days ago
83%
Declines
ODDS (%)
Bearish Trend 12 days ago
90%
Bearish Trend 12 days ago
84%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
N/A
Bearish Trend 12 days ago
85%
View a ticker or compare two or three
Ad is loading...
ITRM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSUSX51.860.48
+0.93%
Goldman Sachs US Equity Insights C
AMFEX18.390.16
+0.88%
AAMA Equity
WSHCX61.780.48
+0.78%
American Funds Washington Mutual C
TIVFX15.590.04
+0.26%
American Beacon EAM Int Small Cap Cl
AAAVX11.780.03
+0.26%
DWS RREEF Real Assets R6

ITRM and

Correlation & Price change

A.I.dvisor indicates that over the last year, ITRM has been loosely correlated with PLRX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if ITRM jumps, then PLRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ITRM
1D Price
Change %
ITRM100%
N/A
PLRX - ITRM
42%
Loosely correlated
-3.36%
ORMP - ITRM
34%
Loosely correlated
-1.72%
RNAZ - ITRM
30%
Poorly correlated
N/A
VKTX - ITRM
29%
Poorly correlated
+0.28%
MDGL - ITRM
29%
Poorly correlated
+7.64%
More

VKTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VKTX has been loosely correlated with JANX. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if VKTX jumps, then JANX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VKTX
1D Price
Change %
VKTX100%
+0.28%
JANX - VKTX
61%
Loosely correlated
+0.27%
DNLI - VKTX
49%
Loosely correlated
+1.20%
LGND - VKTX
44%
Loosely correlated
+0.73%
BEAM - VKTX
41%
Loosely correlated
+0.17%
ALT - VKTX
40%
Loosely correlated
+2.24%
More